The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Regulatory News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Nov 2016 09:36

RNS Number : 7388O
Diurnal Group PLC
09 November 2016
 

9 November 2016

 

Diurnal Group plc

("Diurnal" or the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations.

 

On 8 November 2016 the following par value options over ordinary shares of 5 pence in Diurnal were granted under the Diurnal Group plc Long Term Incentive Plan (the "Plan") to persons discharging managerial responsibilities ("PDMR"):

 

PDMR

Total no. of shares under award

Type of awards

Martin Whitaker

133,333

Performance Share Award

Martin Whitaker

69,565

Deferred Bonus Award

Ian Ardill

81,250

Performance Share Award

Ian Ardill

22,608

Deferred Bonus Award

 

The performance share awards will ordinarily vest no earlier than the third anniversary of their grant subject to the grantee's continued service and to the extent to which the performance conditions set for the awards are satisfied. Such awards may potentially vest until the fifth anniversary of their grant date.

 

The deferred bonus awards will ordinarily vest on the first anniversary of their grant subject to the grantee's continued service.

 

The awards were granted under award agreements that incorporated the terms of the Plan and comprised a mix of tax-favoured 'EMI' awards and non-tax favoured awards.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

Details of the full notifications received by the Company are set out below:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Martin Whitaker

2

Reason for Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Diurnal Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each in Diurnal Group plc

GB00BDB6Q760

b)

Nature of the transaction

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

Non-EMI performance share award over 133,333 ordinary shares.

 

EMI deferred bonus award over 9,730 ordinary shares.

 

Non-EMI deferred bonus award over 59,835 ordinary shares.

 

The performance share award will ordinarily vest no earlier than the third anniversary of its grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such award may potentially vest until the fifth anniversary of its grant date.

 

The deferred bonus awards will ordinarily vest on the first anniversary of their grant subject to continued service.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

133,333

Nil

9,730

Nil

59,835

d)

Aggregated information

- Aggregated volume

- Price

Award over total of 202,898 ordinary shares. Nil price payable for grant.

e)

Date of the transaction

8 November 2016

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ardill

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Diurnal Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each in Diurnal Group plc

GB00BDB6Q760

b)

Nature of the transaction

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

EMI performance share award over 53,323 ordinary shares.

 

Non-EMI performance share award over 27,927 ordinary shares.

 

EMI deferred bonus award over 22,608 ordinary shares.

 

The performance share awards will ordinarily vest no earlier than the third anniversary of their grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such awards may potentially vest until the fifth anniversary of their grant date.

 

The deferred bonus award will ordinarily vest on the first anniversary of its grant subject to continued service.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

53,323

Nil

27,927

Nil

22,608

d)

Aggregated information

- Aggregated volume

- Price

Award over total of 103,858 ordinary shares. Nil price payable for grant.

e)

Date of the transaction

8 November 2016

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information, please visit www.diurnal.co.uk or contact:

Diurnal Group plc

+44 (0)20 3727 1000

Martin Whitaker, CEO

Ian Ardill, CFO

Numis Securities Ltd (Nominated Adviser)

+44 (0)20 7260 1000

Nominated Adviser: Michael Meade, Freddie Barnfield, Paul Gillam

Corporate Broking: James Black

FTI Consulting

+44 (0)20 3727 1000

Simon Conway

Victoria Foster Mitchell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFSMSUUFMSEDF
Date   Source Headline
7th Mar 20222:30 pmRNSScottish Medicines Consortium Update
2nd Mar 20227:00 amRNSRegulatory update on oral native testosterone
1st Mar 202210:23 amRNSTotal Voting Rights
24th Feb 202212:00 pmRNSNotice of Interim Results
10th Feb 20227:00 amRNSFirst patient dosed in Phase 2 trial
9th Feb 20227:00 amRNSIssue of Long-Term Incentive Plan awards
1st Feb 20227:00 amRNSTotal Voting Rights
31st Jan 20221:26 pmRNSPostponement of R&D Day
26th Jan 20227:00 amRNSTrading Update
24th Jan 20227:00 amRNSDiurnal to participate in Edison “Open House”
11th Jan 20227:00 amRNSOperational update
7th Jan 202212:58 pmRNSHolding(s) in Company
13th Dec 202112:46 pmRNSBlock Admission Application
2nd Dec 20217:00 amRNSNotice of R&D Day
19th Nov 202111:43 amRNSResults of AGM
16th Nov 20217:00 amRNSAlkindi approved for use in Switzerland
15th Nov 20215:20 pmRNSEton enters into US co-promotion deal
15th Nov 20217:00 amRNSDirectorate Change
8th Nov 20219:16 amRNSHolding(s) in Company
15th Oct 202111:17 amRNSHolding(s) in Company
14th Oct 20217:01 amRNSAppointment of Joint Corporate Broker
14th Oct 20217:00 amRNSAgreement signed with ExCEEd Orphan for CEE
11th Oct 20217:00 amRNSPhase 1 data for DITEST published in EJE
8th Oct 202112:24 pmRNSExercise of Options, Issue of Equity and TVR
7th Oct 202111:15 amEQSHardman & Co Research | Diurnal (DNL) Life Sciences Investor Forum
6th Oct 20213:53 pmRNSPosting of Annual Report and Notice of AGM
30th Sep 202112:08 pmRNSHolding(s) in Company
29th Sep 20212:35 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSHardman & Co Life Sciences Investor Forum
16th Sep 202110:15 amEQSHardman & Co Research: Diurnal Group (DNL): All set for three pivotal trials
15th Sep 20219:17 amRNSDirector Dealings
14th Sep 20217:00 amRNSResults for the year ended 30 June 2021
13th Sep 20217:00 amRNSCommercial launch of Efmody in the UK
1st Sep 20217:00 amRNSDiurnal launches Efmody in Germany and Austria
19th Aug 20217:00 amRNSFull Year Results Investor Presentation
12th Aug 20217:20 amEQSHardman & Co Video Event | Diurnal Group plc - Investor Forum
2nd Aug 20217:00 amRNSGrant of Deferred Share Awards
28th Jul 20217:00 amRNSBusiness and Trading Update
14th Jul 20217:00 amRNSDirector Dealings
12th Jul 20217:00 amRNSAgreement from US FDA on SPA for Chronocort
9th Jul 20218:30 amRNSDirector Dealings and Issue of Equity
7th Jul 20217:00 amRNSNotice of Full Year Results
5th Jul 20217:00 amRNSShares and AJ Bell Investor Evening Webinar
2nd Jul 20217:00 amRNSMarketing Authorisation for Efmody in GB from MHRA
29th Jun 20217:00 amRNSDistribution agreement with Er-Kim
2nd Jun 202112:19 pmRNSDirector Dealings
1st Jun 20217:00 amRNSDiurnal triggers milestone payments from Citrine
28th May 20212:33 pmRNSEuropean Commission approval received for Efmody
13th May 20217:00 amRNSCorrection: Director Dealings
12th May 20215:32 pmRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.